Newer antibacterial and antimycotic drugs. Critical appraisal.
D000583:Amikacin; D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D002511:Cephalosporins; D002981:Clindamycin; D005437:Flucytosine; D006801:Humans; D007093:Imidazoles; D010406:Penicillins; D012293:Rifampin; D000198:Spectinomycin; D013420:Sulfamethoxazole; D013754:Tetracyclines; D014031:Tobramycin; D014295:Trimethoprim
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D002511:Cephalosporins; D007093:Imidazoles; D010406:Penicillins; D013754:Tetracyclines; D002981:Clindamycin; D000583:Amikacin; D000198:Spectinomycin; D014295:Trimethoprim; D005437:Flucytosine; D013420:Sulfamethoxazole; D012293:Rifampin; D014031:Tobramycin